Page last updated: 2024-10-26

dipyridamole and IgA Vasculitis

dipyridamole has been researched along with IgA Vasculitis in 8 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

IgA Vasculitis: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.

Research Excerpts

ExcerptRelevanceReference
"The effect of dipyridamole on proteinuria was studied in 60 children with various renal diseases."7.67Effect of dipyridamole treatment on proteinuria in pediatric renal disease. ( Ito, S; Kawaguchi, S; Niinomi, Y; Nonoda, T; Ohnishi, M; Ueda, N; Yasaki, T, 1986)
"From 1980 through 1992, 14 children with Henoch-Schönlein nephritis (HSN) showing severe glomerular changes (grade IV or V) were given a multiple combined therapy with prednisolone, cyclophosphamide, heparin/warfarin, and dipyridamole, and were followed for 7."3.70Multiple combined therapy for severe Henoch-Schönlein nephritis in children. ( Iijima, K; Ito-Kariya, S; Nakamura, H; Yoshikawa, N, 1998)
"The effect of dipyridamole on proteinuria was studied in 60 children with various renal diseases."3.67Effect of dipyridamole treatment on proteinuria in pediatric renal disease. ( Ito, S; Kawaguchi, S; Niinomi, Y; Nonoda, T; Ohnishi, M; Ueda, N; Yasaki, T, 1986)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ninchoji, T1
Kaito, H1
Nozu, K1
Hashimura, Y1
Kanda, K1
Kamioka, I1
Shima, Y1
Hamahira, K1
Nakanishi, K1
Tanaka, R1
Yoshikawa, N2
Iijima, K2
Matsuo, M1
Lin, Q1
Min, Y1
Li, Y1
Zhu, Y1
Song, X1
Xu, Q1
Wang, L1
Cheng, J1
Feng, Q1
Li, X1
Tanaka, H1
Suzuki, K1
Nakahata, T1
Ito, E1
Waga, S1
Oner, A1
Tinaztepe, K1
Erdogan, O1
Yasukawa, K1
Kohno, M1
Ohmoto, A1
Matsuyama, R1
Ito-Kariya, S1
Nakamura, H1
McKenzie, PE1
Taylor, AE1
Woodroffe, AJ1
Seymour, AE1
Chan, YL1
Clarkson, AR1
Ueda, N1
Kawaguchi, S1
Niinomi, Y1
Nonoda, T1
Ohnishi, M1
Ito, S1
Yasaki, T1

Trials

2 trials available for dipyridamole and IgA Vasculitis

ArticleYear
Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.
    Pediatric nephrology (Berlin, Germany), 2003, Volume: 18, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combinati

2003
The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis.
    Pediatric nephrology (Berlin, Germany), 1995, Volume: 9, Issue:1

    Topics: Adolescent; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephr

1995

Other Studies

6 other studies available for dipyridamole and IgA Vasculitis

ArticleYear
Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.
    Pediatric nephrology (Berlin, Germany), 2011, Volume: 26, Issue:4

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents

2011
Henoch-Schönlein purpura with hypocomplementemia.
    Pediatric nephrology (Berlin, Germany), 2012, Volume: 27, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antistreptolysin; Autoantibodies; Biopsy; Child; Ch

2012
[Henoch-Schönlein nephritis with nephrotic syndrome during pregnancy].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1996, Volume: 19, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Dipyridamole; Female; Heparin; HLA-DQ Antigens; HLA

1996
Multiple combined therapy for severe Henoch-Schönlein nephritis in children.
    Pediatric nephrology (Berlin, Germany), 1998, Volume: 12, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Fema

1998
Plasmapheresis in glomerulonephritis.
    Clinical nephrology, 1979, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System

1979
Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
    Nephron, 1986, Volume: 44, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Dipyridamole; Female; Glomerulonephritis; Glom

1986